In vitro and ex vivo correlation of drug release from ophthalmic ointments

被引:56
作者
Bao, Quanying [1 ]
Newman, Bryan [2 ]
Wang, Yan [2 ]
Choi, Stephanie [2 ]
Burgess, Diane J. [1 ]
机构
[1] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA
[2] US FDA, CDER, Off Gener Drugs, Off Res & Stand,Div Therapeut Performance, Silver Spring, MD 20993 USA
关键词
Ophthalmic ointment; Lotemax; In vitro; Ex vivo; Transcorneal; Rabbit corneas; Franz diffusion cells; Hydroxypropyl-beta-cyclodextrin; EXCISED RABBIT CORNEA; POLYMERIC MICROSPHERES; LOTEPREDNOL ETABONATE; OCULAR DELIVERY; SITU GEL; FORMULATION; PERMEATION; ACETAZOLAMIDE; EPITHELIUM; SYSTEMS;
D O I
10.1016/j.jconrel.2018.03.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In vitro drug release testing and ex vivo transcorneal drug permeation can provide valuable information on the performance of the Q1/Q2 equivalent ointments prior to any animal studies. Good correlation between in vitro and ex vivo drug release may be indicative of good in vitro and in vivo correlation. Accordingly, it is important to investigate in vitro as well as ex vivo drug release from Q1/Q2 equivalent ophthalmic ointments and evaluate whether a correlation between these release profiles can be established. Four Q1/Q2 equivalent loteprednol etabonate ointments were prepared using different processing methods and excipient sources. The rheological parameters (crossover modulus and K value) of the four formulations were determined. The in vitro drug release testing of the four ointment formulations were performed using three different apparati (Franz diffusion cells, USP apparatus 2 with enhancer cells and USP apparatus 4 with semisolid adapters). Three models (zero order, logarithmic and the Higuchi model) were used to study the release kinetics of the ointment formulations. The transcorneal (rabbit corneas) permeation studies were performed using spherical joint Franz diffusion cells. The USP apparatus 4 method demonstrated better discriminatory ability compared to the USP apparatus 2 and the Franz diffusion cell methods. The in vitro release profiles of the four Q1/Q2 equivalent ointments with manufacturing differences showed a better fit using the Higuchi model (R-2 > 0.98) for all three release testing methods, compared to the other two models. Ex vivo drug release through the rabbit corneas displayed zero order release kinetics. A logarithmic correlation between rheological parameters (crossover and K value) and transcorneal flux were established. In addition, a plot of the in vitro release rate against the ex vivo release flux of the four ointment formulations, yielded a straight line (R-2 > 0.98) for all three release methods. Accordingly, the rheological parameters may be useful in predicting in vitro as well as ex vivo release properties.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 25 条
[1]   In vitro and ex vivo corneal penetration and absorption models [J].
Agarwal, Priyanka ;
Rupenthal, Ilva D. .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2016, 6 (06) :634-647
[2]   Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres [J].
Andhariya, Janki V. ;
Shen, Jie ;
Choi, Stephanie ;
Wang, Yan ;
Zou, Yuan ;
Burgess, Diane J. .
JOURNAL OF CONTROLLED RELEASE, 2017, 255 :27-35
[3]   In vitro release testing method development for ophthalmic ointments [J].
Bao, Quanying ;
Shen, Jie ;
Jog, Rajan ;
Zhang, Carmen ;
Newman, Bryan ;
Wang, Yan ;
Choi, Stephanie ;
Burgess, Diane J. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 526 (1-2) :145-156
[4]   Physicochemical attributes and dissolution testing of ophthalmic ointments [J].
Bao, Quanying ;
Jog, Rajan ;
Shen, Jie ;
Newman, Bryan ;
Wang, Yan ;
Choi, Stephanie ;
Burgess, Diane J. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 523 (01) :310-319
[5]   Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems [J].
Bodor, N ;
Buchwald, P .
AAPS JOURNAL, 2005, 7 (04) :E820-E833
[6]  
Burgalassi S, 2004, J OCUL PHARMACOL TH, V20, P518, DOI 10.1089/jop.2004.20.518
[7]  
Chang-Lin J., 1969, DRUG TRANSPORT MECH
[8]  
Destruel PL, 2017, DRUG DISCOV TODAY, V22, P638, DOI 10.1016/j.drudis.2016.12.008
[9]  
European Medicines Agency, 2014, BACKGR REV CYCL US E
[10]   Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies [J].
Fathalla, Zeinab M. A. ;
Vangala, Anil ;
Longman, Michael ;
Khaled, Khaled A. ;
Hussein, Amal K. ;
El-Garhy, Omar H. ;
Alany, Raid G. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 114 :119-134